Ra Medical Systems (RMED) Misses Q4 EPS by 38c

Ra Medical Systems (NYSE: RMED) reported Q4 EPS of ($1.23), $0.38 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $5 thousand versus the consensus estimate of $350 thousand.

For earnings history and earnings-related data on Ra Medical Systems (RMED) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance